Partially functional hypomorphic missense variants in BRCA2 are reduced penetrance pathogenic variants
Identification of partial loss-of-function (hypomorphic), reduced penetrance pathogenic missense variants (RPPVs) and assessment of the clinical relevance of these variants is needed for improved hereditary cancer risk estimation. Here we show that 70 candidate hypomorphic missense variants in the DNA-binding domain of BRCA2 reduce homologous recombination DNA repair activity and endogenous cell survival, decrease RAD51 foci formation, and increase sensitivity to Poly(ADP-ribose) polymerase inhibitors. The 34 "strong" hypomorphs with greatest effects on function are associated with moderate risks of female breast cancer and later ages of diagnosis than pathogenic variants (PVs), and 14 of these variants can be classified as "likely pathogenic" by integration of functional data into a ClinGen BRCA1/2 variant curation model. In addition, 32% of tumors with hypomorphic variants and corresponding loss of heterozygosity for BRCA2 display homologous recombination deficiency (HRD) compared to 83% of tumors with PVs and 7% with benign variants. These RPPVs represent a class of BRCA2 variants that have implications for the clinical management of carriers.
Authors
- Chunling Hu (ORCID: https://orcid.org/0000-0002-6814-4639)
- Rohan David Gnanaolivu (ORCID: https://orcid.org/0000-0001-6995-6340)
- Lisa N. Heppler (ORCID: https://orcid.org/0009-0002-9737-8802)
- Rachid Karam (ORCID: https://orcid.org/0000-0002-5645-498X)
- Paulo Cilas Morais Lyra Junior (ORCID: https://orcid.org/0000-0002-4403-6684)
- Matthew T. Kucera
- Brennan James Decker (ORCID: https://orcid.org/0000-0003-4516-7421)
- Fergus J. Couch (ORCID: https://orcid.org/0000-0001-9417-9985)
- Colin C. Young (ORCID: https://orcid.org/0000-0002-9385-8262)
- Amik Munankarmy (ORCID: https://orcid.org/0000-0001-7572-1169)
- Ronan E. Couch (ORCID: https://orcid.org/0009-0002-0235-6484)
- Kelly Fulk (ORCID: https://orcid.org/0000-0002-4517-9046)
- Marcy E. Richardson (ORCID: https://orcid.org/0000-0002-4626-4920)
- Tina F. Pesaran (ORCID: https://orcid.org/0000-0001-9807-4304)
- Tuya Pal (ORCID: https://orcid.org/0000-0001-8009-2475)
- Timothy C. Simmons (ORCID: https://orcid.org/0000-0001-5741-4763)
- Yen Y. Tan (ORCID: https://orcid.org/0000-0003-1063-5352)
- Benjamin P. Persons (ORCID: https://orcid.org/0009-0005-6984-9816)
- Jamie D. Weyandt (ORCID: https://orcid.org/0000-0001-5602-5782)
- Erin Mundt
- Elisha Hughes (ORCID: https://orcid.org/0000-0002-3145-3913)
- Scott H. Kaufmann (ORCID: https://orcid.org/0000-0002-4900-7145)
- Huaizhi Huang (ORCID: https://orcid.org/0009-0001-6186-7228)
- Wenan Chen (ORCID: https://orcid.org/0000-0003-0379-2368)
- Susan M. Domchek (ORCID: https://orcid.org/0000-0002-5914-7272)
- Álvaro N.A. Monteiro (ORCID: https://orcid.org/0000-0002-8448-4801)
- Christen M. Csuy
- Katherine L. Nathanson (ORCID: https://orcid.org/0000-0002-6740-0901)
- Siddhartha Yadav (ORCID: https://orcid.org/0000-0003-4630-9903)
- Nicholas James Boddicker (ORCID: https://orcid.org/0000-0002-6784-2072)
- Steven N. Hart (ORCID: https://orcid.org/0000-0001-7714-2734)
- Jie Na (ORCID: https://orcid.org/0000-0003-3435-1805)
- Kevin L. Peterson (ORCID: https://orcid.org/0000-0002-8415-5426)
- Christina A. Seelaus
- Olivia K. Rossman
- Mohamed Abozaid (ORCID: https://orcid.org/0009-0008-5475-6619)
- Andrew Goldfarb
- Zahra Heidari
Institutions
- Mayo Clinic (US)
- Moffitt Cancer Center (US)
- Ambry Genetics (United States) (US)
- Myriad Genetics (US)
- Vanderbilt-Ingram Cancer Center (US)
- Foundation Medicine (United States) (US)
- Medical University of Vienna (AT)
- University of Pennsylvania (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1038/s41467-026-79433-5
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Breast Cancer Research Foundation
- National Institutes of Health
- National Cancer Institute